These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12791957)

  • 1. Heart disease. How to subdue a swelling heart.
    Marx J
    Science; 2003 Jun; 300(5625):1492-6. PubMed ID: 12791957
    [No Abstract]   [Full Text] [Related]  

  • 2. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulating cardiac contractility in heart failure: data from mice and men.
    Dorn GW; Molkentin JD
    Circulation; 2004 Jan; 109(2):150-8. PubMed ID: 14734503
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abnormal myocardial contractile regulation mechanism in familial hypertrophic and dilated cardiomyopathies--functional analysis of molecular mutant troponin in in-vitro].
    Morimoto S
    Fukuoka Igaku Zasshi; 2002 Jan; 93(1):1-5. PubMed ID: 11889827
    [No Abstract]   [Full Text] [Related]  

  • 6. Disease-modifying mutations in familial hypertrophic cardiomyopathy: complexity from simplicity.
    Hilfiker-Kleiner D; Knöll R
    Circulation; 2008 Apr; 117(14):1775-7. PubMed ID: 18391120
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
    Minamisawa S; Hoshijima M; Chu G; Ward CA; Frank K; Gu Y; Martone ME; Wang Y; Ross J; Kranias EG; Giles WR; Chien KR
    Cell; 1999 Oct; 99(3):313-22. PubMed ID: 10555147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
    Haghighi K; Gregory KN; Kranias EG
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1214-22. PubMed ID: 15336969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholamban: a crucial regulator of cardiac contractility.
    MacLennan DH; Kranias EG
    Nat Rev Mol Cell Biol; 2003 Jul; 4(7):566-77. PubMed ID: 12838339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy.
    Hoshijima M; Knöll R; Pashmforoush M; Chien KR
    J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profile in dilated cardiomyopathy caused by elevated frequencies of mitochondrial DNA mutations in the mouse heart.
    Zhang D; Ezekiel UR; Chang SW; Zassenhaus HP
    Cardiovasc Pathol; 2005; 14(2):61-9. PubMed ID: 15780797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy.
    Chiu C; Tebo M; Ingles J; Yeates L; Arthur JW; Lind JM; Semsarian C
    J Mol Cell Cardiol; 2007 Sep; 43(3):337-43. PubMed ID: 17655857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered intracellular Ca2+ handling in heart failure.
    Yano M; Ikeda Y; Matsuzaki M
    J Clin Invest; 2005 Mar; 115(3):556-64. PubMed ID: 15765137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium handler mishandles heart.
    Champion HC; Kass DA
    Nat Med; 2004 Mar; 10(3):239-40. PubMed ID: 14991046
    [No Abstract]   [Full Text] [Related]  

  • 17. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy.
    Davis J; Davis LC; Correll RN; Makarewich CA; Schwanekamp JA; Moussavi-Harami F; Wang D; York AJ; Wu H; Houser SR; Seidman CE; Seidman JG; Regnier M; Metzger JM; Wu JC; Molkentin JD
    Cell; 2016 May; 165(5):1147-1159. PubMed ID: 27114035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation.
    Du CK; Morimoto S; Nishii K; Minakami R; Ohta M; Tadano N; Lu QW; Wang YY; Zhan DY; Mochizuki M; Kita S; Miwa Y; Takahashi-Yanaga F; Iwamoto T; Ohtsuki I; Sasaguri T
    Circ Res; 2007 Jul; 101(2):185-94. PubMed ID: 17556660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart.
    Parlakian A; Charvet C; Escoubet B; Mericskay M; Molkentin JD; Gary-Bobo G; De Windt LJ; Ludosky MA; Paulin D; Daegelen D; Tuil D; Li Z
    Circulation; 2005 Nov; 112(19):2930-9. PubMed ID: 16260633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.